Gaell Mayer
BioPharmaceuticals R&D, AstraZeneca
Goeteborg, O 41314, Sweden
Goeteborg, O 41314, Sweden
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
ARL5b inhibits human rhinovirus 16 propagation and impairs macrophage-mediated bacterial clearance.
Journal: EMBO reports
Published: May 01, 2023
Tissue Infiltrating LTi-Like Group 3 Innate Lymphoid Cells and T Follicular Helper Cells in Graves' and Hashimoto's Thyroiditis.
Journal: Frontiers in immunology
Published: October 08, 2019
Arpin is critical for phagocytosis in macrophages and is targeted by human rhinovirus.
Journal: EMBO reports
Published: February 20, 2019
HRV16 Impairs Macrophages Cytokine Response to a Secondary Bacterial Trigger.
Journal: Frontiers in immunology
Published: July 06, 2018
Differential Effect of LPS on Glucose, Lactate and Inflammatory Markers in the Lungs of Normal and Diabetic Mice.
Journal: Journal of pulmonary & respiratory medicine
Published: June 26, 2018
Human FOXP3+ T regulatory cell heterogeneity.
Journal: Clinical & translational immunology
Published: October 02, 2017
Assessing the Relationship between Lung Density and Function with Oxygen-Enhanced Magnetic Resonance Imaging in a Mouse Model of Emphysema.
Journal: PloS one
Published: October 01, 2015
Partial agonist activity of R3(BΔ23-27)R/I5 at RXFP3--investigation of in vivo and in vitro pharmacology.
Journal: European journal of pharmacology
Published: June 30, 2014
Showing 1-8 of 8
Last Updated: 09/26/2026